Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Elizagarate, E; Cortes, J; Pinto, AG; Gutierrez, M; Alonso, I; Alcorta, P; Ramirez, M; de Heredia, JLP
   Study of the influence of electroconvulsive therapy or cerebral blood flowby HMPAO-SPECT
   JOURNAL OF AFFECTIVE DISORDERS
   
   E. Elizagarate et al., "Study of the influence of electroconvulsive therapy or cerebral blood flowby HMPAO-SPECT", J AFFECT D, 65(1), 2001, pp. 55-59
2. Kugaya, A; Fujita, M; Innis, RB
   Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders
   ANNALS OF NUCLEAR MEDICINE
   
   A. Kugaya et al., "Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders", ANN NUCL M, 14(1), 2000, pp. 1-9
3. Fitzgerald, PB; Kapur, S; Caligiuri, MP; Jones, C; Silvestri, S; Remington, G; Zipursky, RB
   Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade
   NEUROPSYCHOPHARMACOLOGY
   
   P.B. Fitzgerald et al., "Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade", NEUROPSYCH, 22(1), 2000, pp. 19-26
4. Patat, A
   Clinical pharmacology of psychotropic drugs
   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
   
   A. Patat, "Clinical pharmacology of psychotropic drugs", HUM PSYCHOP, 15(5), 2000, pp. 361-387
5. Laruelle, M
   Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
   
   M. Laruelle, "Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review", J CEREBR B, 20(3), 2000, pp. 423-451
6. Bergstrom, KA; Harkonen, R; Kairemo, K; Karonen, SL; Knuuti, J; Kuikka, JT; Lamberg, BA; Lansimies, E; Liewendahl, K; Nikkinen, P; Rekonen, A; Savolainen, S; Vanninen, E; Vauramo, E; Wegelius, U
   The development of nuclear medicine in Finland: a review on the occasion of the 40th anniversary of the Finnish Society of Nuclear Medicine
   CLINICAL PHYSIOLOGY
   
   K.A. Bergstrom et al., "The development of nuclear medicine in Finland: a review on the occasion of the 40th anniversary of the Finnish Society of Nuclear Medicine", CLIN PHYSL, 20(5), 2000, pp. 317-329
7. Fitzgerald, PB; Kapur, S; Remington, G; Roy, P; Zipursky, RB
   Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels
   PSYCHOPHARMACOLOGY
   
   P.B. Fitzgerald et al., "Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels", PSYCHOPHAR, 149(1), 2000, pp. 1-5
8. Bartenstein, P; Grunwald, F; Kuwert, T; Tatsch, K; Sabri, O; Benkert, O; Fahlbusch, R; Grunder, G; Herholz, K; Weiller, C
   Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma
   NUKLEARMEDIZIN-NUCLEAR MEDICINE
   
   P. Bartenstein et al., "Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma", NUKLEARMED, 39(8), 2000, pp. 218-232
9. Okubo, Y; Olsson, H; Ito, H; Lofti, M; Suhara, T; Halldin, C; Farde, L
   PET mapping of extrastriatal D2-like dopamine receptors in the human brainusing an anatomic standardization technique and [C-11]FLB 457
   NEUROIMAGE
   
   Y. Okubo et al., "PET mapping of extrastriatal D2-like dopamine receptors in the human brainusing an anatomic standardization technique and [C-11]FLB 457", NEUROIMAGE, 10(6), 1999, pp. 666-674
10. Hietala, J
    Ligand-receptor interactions studied by PET: implications for drug development
    ANNALS OF MEDICINE
    
    J. Hietala, "Ligand-receptor interactions studied by PET: implications for drug development", ANN MED, 31(6), 1999, pp. 438-443
11. Holden, RJ
    The role of brain insulin in the neurophysiology of serious mental disorders: review
    MEDICAL HYPOTHESES
    
    R.J. Holden, "The role of brain insulin in the neurophysiology of serious mental disorders: review", MED HYPOTH, 52(3), 1999, pp. 193-200
12. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
    Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    J. Hietala et al., "Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis", J CEREBR B, 19(2), 1999, pp. 210-217
13. Laruelle, M; Abi-Dargham, P
    Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
    JOURNAL OF PSYCHOPHARMACOLOGY
    
    M. Laruelle e P. Abi-Dargham, "Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies", J PSYCHOPH, 13(4), 1999, pp. 358-371
14. Wang, GJ; Volkow, ND; Fowler, JS; Logan, J; Pappas, NR; Wong, CT; Hitzemann, RJ; Netusil, N
    Reproducibility of repeated measures of endogenous dopamine competition with [C-11]raclopride in the human brain in response to methylphenidate
    JOURNAL OF NUCLEAR MEDICINE
    
    G.J. Wang et al., "Reproducibility of repeated measures of endogenous dopamine competition with [C-11]raclopride in the human brain in response to methylphenidate", J NUCL MED, 40(8), 1999, pp. 1285-1291
15. Gustavsson, JP; Nothen, MM; Jonsson, EG; Neidt, H; Forslund, K; Rylander, G; Mattila-Evenden, M; Sedvall, GC; Propping, P; Asberg, M
    No association between serotonin transporter gene polymorphisms and personality traits
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    J.P. Gustavsson et al., "No association between serotonin transporter gene polymorphisms and personality traits", AM J MED G, 88(4), 1999, pp. 430-436
16. Verhoeff, NPLG
    Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
    PSYCHOPHARMACOLOGY
    
    N.P.L.G. Verhoeff, "Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders", PSYCHOPHAR, 147(3), 1999, pp. 217-249
17. BRYANT CA; JACKSON SHD
    FUNCTIONAL IMAGING OF THE BRAIN IN THE EVALUATION OF DRUG RESPONSE AND ITS APPLICATION TO THE STUDY OF AGING
    Drugs & aging
    
    C.A. Bryant e S.H.D. Jackson, "FUNCTIONAL IMAGING OF THE BRAIN IN THE EVALUATION OF DRUG RESPONSE AND ITS APPLICATION TO THE STUDY OF AGING", Drugs & aging, 13(3), 1998, pp. 211-222
18. HAGBERG G; GEFVERT O; BERGSTROM M; WIESELGREN IM; LINDSTROM L; WIESEL FA; LANGSTROM B
    N-[C-11]METHYLSPIPERONE PET, IN CONTRAST TO [C-11] RACLOPRIDE, FAILS TO DETECT D-2 RECEPTOR OCCUPANCY BY AN ATYPICAL NEUROLEPTIC
    PSYCHIATRY RESEARCH-NEUROIMAGING
    
    G. Hagberg et al., "N-[C-11]METHYLSPIPERONE PET, IN CONTRAST TO [C-11] RACLOPRIDE, FAILS TO DETECT D-2 RECEPTOR OCCUPANCY BY AN ATYPICAL NEUROLEPTIC", PSYCHIATRY RESEARCH-NEUROIMAGING, 82(3), 1998, pp. 147-160
19. KUIKKA J; TIIHONEN J
    FRACTAL ANALYSIS - A NEW APPROACH IN BRAIN RECEPTOR IMAGING
    Annals of medicine
    
    J. Kuikka e J. Tiihonen, "FRACTAL ANALYSIS - A NEW APPROACH IN BRAIN RECEPTOR IMAGING", Annals of medicine, 30(3), 1998, pp. 242-248
20. RYDING E; TUNINGER E; OHLSSON T; SJOHOLM H; FRECCEROROSMAN K; LEVANDER S; ROSEN I
    DOPAMINE D2-RECEPTOR DENSITY IN HUMANS AS ASSESSED WITH SPET AND THE NEW HIGH-AFFINITY LIGAND I-123 NCQ298 - A PILOT-STUDY
    Nuclear medicine communications
    
    E. Ryding et al., "DOPAMINE D2-RECEPTOR DENSITY IN HUMANS AS ASSESSED WITH SPET AND THE NEW HIGH-AFFINITY LIGAND I-123 NCQ298 - A PILOT-STUDY", Nuclear medicine communications, 19(3), 1998, pp. 263-270
21. Kuwert, T; Bartenstein, P; Grunwald, F; Herholz, K; Larisch, R; Sabri, O; Biersack, HJ; Moser, E; Muller, HW; Muller-Gartner, HW; Schober, O; Schwaiger, M; Bull, U; Heiss, WD
    Clinical significance of positron emission tomography in neuromedicine. A position paper on the results of an interdisciplinary consensus conference
    NERVENARZT
    
    T. Kuwert et al., "Clinical significance of positron emission tomography in neuromedicine. A position paper on the results of an interdisciplinary consensus conference", NERVENARZT, 69(12), 1998, pp. 1045-1060
22. Zawarynski, P; Tallerico, T; Seeman, P; Lee, SP; O'Dowd, BF; George, SR
    Dopamine D2 receptor dimers in human and rat brain
    FEBS LETTERS
    
    P. Zawarynski et al., "Dopamine D2 receptor dimers in human and rat brain", FEBS LETTER, 441(3), 1998, pp. 383-386
23. WILSON JM; SANYAL S; VANTOL HHM
    DOPAMINE D-2 AND D-4 RECEPTOR LIGANDS - RELATION TO ANTIPSYCHOTIC ACTION
    European journal of pharmacology
    
    J.M. Wilson et al., "DOPAMINE D-2 AND D-4 RECEPTOR LIGANDS - RELATION TO ANTIPSYCHOTIC ACTION", European journal of pharmacology, 351(3), 1998, pp. 273-286
24. TRAVIS MJ; KERWIN R
    NEUROIMAGING
    Current opinion in psychiatry
    
    M.J. Travis e R. Kerwin, "NEUROIMAGING", Current opinion in psychiatry, 10(1), 1997, pp. 16-25
25. KEGELES LS; MANN JJ
    IN-VIVO IMAGING OF NEUROTRANSMITTER SYSTEMS USING RADIOLABELED RECEPTOR LIGANDS
    Neuropsychopharmacology
    
    L.S. Kegeles e J.J. Mann, "IN-VIVO IMAGING OF NEUROTRANSMITTER SYSTEMS USING RADIOLABELED RECEPTOR LIGANDS", Neuropsychopharmacology, 17(5), 1997, pp. 293-307
26. SEEMAN P; CORBETT R; VANTOL HHM
    ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - REPLY
    Neuropsychopharmacology
    
    P. Seeman et al., "ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - REPLY", Neuropsychopharmacology, 16(2), 1997, pp. 127-135
27. NYBERG S; FARDE L; HALLDIN C
    A PET STUDY OF 5-HT2 AND D-2 DOPAMINE-RECEPTOR OCCUPANCY INDUCED BY OLANZAPINE IN HEALTHY-SUBJECTS
    Neuropsychopharmacology
    
    S. Nyberg et al., "A PET STUDY OF 5-HT2 AND D-2 DOPAMINE-RECEPTOR OCCUPANCY INDUCED BY OLANZAPINE IN HEALTHY-SUBJECTS", Neuropsychopharmacology, 16(1), 1997, pp. 1-7
28. LARUELLE M; IYER RN; ALTIKRITI MS; ZEAPONCE Y; MALISON R; ZOGHBI SS; BALDWIN RM; KUNG HF; CHARNEY DS; HOFFER PB; INNIS RB; BRADBERRY CW
    MICRODIALYSIS AND SPECT MEASUREMENTS OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN NONHUMAN-PRIMATES
    Synapse
    
    M. Laruelle et al., "MICRODIALYSIS AND SPECT MEASUREMENTS OF AMPHETAMINE-INDUCED DOPAMINE RELEASE IN NONHUMAN-PRIMATES", Synapse, 25(1), 1997, pp. 1-14
29. TARAZI FI; FLORIJN WJ; CREESE I
    DIFFERENTIAL REGULATION OF DOPAMINE-RECEPTORS AFTER CHRONIC TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUG-TREATMENT
    Neuroscience
    
    F.I. Tarazi et al., "DIFFERENTIAL REGULATION OF DOPAMINE-RECEPTORS AFTER CHRONIC TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUG-TREATMENT", Neuroscience, 78(4), 1997, pp. 985-996
30. HIETALA J; KUOPPAMAKI M; NAGREN K; LEHIKOINEN P; SYVALAHTI E
    EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY
    Psychopharmacology
    
    J. Hietala et al., "EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY", Psychopharmacology, 132(4), 1997, pp. 361-365
31. NYBERG S; FARDE L; HALLDIN C
    TEST-RETEST RELIABILITY OF CENTRAL [C-11] RACLOPRIDE BINDING AT HIGH D-2 RECEPTOR OCCUPANCY - A PET STUDY IN HALOPERIDOL-TREATED PATIENTS
    PSYCHIATRY RESEARCH-NEUROIMAGING
    
    S. Nyberg et al., "TEST-RETEST RELIABILITY OF CENTRAL [C-11] RACLOPRIDE BINDING AT HIGH D-2 RECEPTOR OCCUPANCY - A PET STUDY IN HALOPERIDOL-TREATED PATIENTS", PSYCHIATRY RESEARCH-NEUROIMAGING, 67(3), 1996, pp. 163-171
32. HEINZ A; KNABLE MB; WEINBERGER DR
    DOPAMINE D-2 RECEPTOR IMAGING AND NEUROLEPTIC DRUG RESPONSE
    The Journal of clinical psychiatry
    
    A. Heinz et al., "DOPAMINE D-2 RECEPTOR IMAGING AND NEUROLEPTIC DRUG RESPONSE", The Journal of clinical psychiatry, 57, 1996, pp. 84-88
33. GRASBY P; MALIZIA A; BENCH C
    PSYCHOPHARMACOLOGY - IN-VIVO NEUROCHEMISTRY AND PHARMACOLOGY
    British Medical Bulletin
    
    P. Grasby et al., "PSYCHOPHARMACOLOGY - IN-VIVO NEUROCHEMISTRY AND PHARMACOLOGY", British Medical Bulletin, 52(3), 1996, pp. 513-526
34. NG GYK; ODOWD BF; LEE SP; CHUNG HT; BRANN MR; SEEMAN P; GEORGE SR
    DOPAMINE D2 RECEPTOR DIMERS AND RECEPTOR-BLOCKING PEPTIDES
    Biochemical and biophysical research communications
    
    G.Y.K. Ng et al., "DOPAMINE D2 RECEPTOR DIMERS AND RECEPTOR-BLOCKING PEPTIDES", Biochemical and biophysical research communications, 227(1), 1996, pp. 200-204
35. TIIHONEN J; KUOPPAMAKI M; NAGREN K; BERGMAN J; ERONEN E; SYVALAHTI E; HIETALA J
    SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY
    Psychopharmacology
    
    J. Tiihonen et al., "SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY", Psychopharmacology, 126(4), 1996, pp. 277-280
36. MORTIMER AM
    NEWER AND OLDER ANTIPSYCHOTICS - A COMPARATIVE REVIEW OF APPROPRIATE USE
    CNS DRUGS
    
    A.M. Mortimer, "NEWER AND OLDER ANTIPSYCHOTICS - A COMPARATIVE REVIEW OF APPROPRIATE USE", CNS DRUGS, 2(5), 1994, pp. 381-396